Director, Agricultural Field Sales - East
Inari AgricultureSalary not specified
- Full Time
- Senior (5 to 8 years)
About Inari Agriculture
Inari Agriculture focuses on improving crop performance through advanced genetic research. The company uses CRISPR technology to make precise modifications to plant DNA, enhancing traits that lead to better yields and resilience. Inari's process begins with building genetic knowledge to identify beneficial traits, followed by generating diversity through targeted genetic changes. The resulting enhancements are integrated into elite parent seeds, which are then distributed through partnerships with seed companies to reach farmers. This model allows Inari to provide seeds that promise higher yields and better performance in challenging environments. Unlike many competitors, Inari emphasizes a scientific approach to genetic enhancement, ensuring that their products are based on deep genetic insights. The company's goal is to support farmers and agricultural businesses by delivering innovative solutions that improve crop productivity and sustainability.
Cambridge, MassachusettsHeadquarters
2016Year Founded
$691.6MTotal Funding
LATE_VCCompany Stage
Food & Agriculture, BiotechnologyIndustries
201-500Employees
Benefits
Health insurance package
Flexible PTO
401k plan
Performance Bonus
Commuter Checks & Assistance
Company Social Events
Free Lunch or Snacks
Risks
Increased competition from Asian agtech startups may challenge Inari's market position.
Reliance on CRISPR technology may lead to regulatory challenges and public scrutiny.
High valuation raises investor expectations, pressuring Inari to deliver rapid growth.
Differentiation
Inari uses CRISPR technology for precise and controlled genetic modifications in plants.
The SEEDesign platform enhances crops for any geography with a clear market approach.
Inari partners with seed companies to scale production and deliver enhanced seeds to farmers.
Upsides
Inari raised $144 million, increasing its valuation to $2.17 billion in 2024.
The rise in agricultural gene editing investments suggests a favorable climate for Inari.
Emerging Asian markets offer new partnership and expansion opportunities for Inari.
Funding
Total raised$691.61 M
Latest valuation$2.17 B
StageLATE_VC
SERIES E
9/30/2022$124
$1.50 BDEBT
3/31/2020$45
$87
$436.50 MSERIES B
7/31/2018$40
$200.00 MSERIES A
9/30/2013$5
$23.50 M